Causal link between gut microbiome and schizophrenia: a Mendelian randomization study

被引:1
作者
Zeng, Qi [1 ]
Zhang, Min [1 ]
Wang, Renxi [1 ]
机构
[1] Capital Med Univ, Beijing Inst Brain Disorders, Collaborat Innovat Ctr Brain Disorders, Lab Brain Disorders,Minist Sci & Technol, 10 Xitoutiao, Beijing 100069, Peoples R China
基金
中国国家自然科学基金;
关键词
genetic variants; gut microbiome; GWAS; Mendelian randomization; schizophrenia; MAJOR DEPRESSIVE DISORDER; VITAMIN-D; GENETICS; ASSOCIATION; DISEASE; GENOME;
D O I
10.1097/YPG.0000000000000361
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
ObjectiveSome observational studies have shown that gut microbiome is significantly changed in patients with schizophrenia. We aim to identify the genetic causal link between gut microbiome and schizophrenia.MethodsA two-sample Mendelian randomization (MR) study was used to evaluate the causal link between gut microbiome and schizophrenia with 28 gut microbiome-associated genetic instrumental variants chosen from recent MR reports and the largest schizophrenia genome-wide association studies (8-Apr-22 release).ResultsInverse variance weighted method showed that genetically increased Bacteroidales_S24-7 (per SD) resulted in increased risk of schizophrenia (OR = 1.110, 95% CI: [1.012-1.217], P = 0.027). Similarly, genetically increased Prevotellaceae promoted schizophrenia risk (OR = 1.124, 95% CI: [1.030-1.228], P = 0.009). However, genetically increased Lachnospiraceae reduced schizophrenia risk (OR = 0.878, 95% CI: [0.785-0.983], P = 0.023). In addition, schizophrenia risk was also suppressed by genetically increased Lactobacillaceae (OR = 0.878, 95% CI: [0.776-0.994], P = 0.040) and Verrucomicrobiaceae (OR = 0.860, 95% CI: [0.749-0.987], P = 0.032). Finally, we did not find any significant results in the causal association of other 23 gut microbiome with schizophrenia.ConclusionOur analysis suggests that genetically increased Bacteroidales_S24-7 and Prevotellaceae promotes schizophrenia risk, whereas genetically increased Lachnospiraceae, Lactobacillaceae, and Verrucomicrobiaceae reduces schizophrenia risk. Thus, regulation of the disturbed intestinal microbiota may represent a new therapeutic strategy for patients with schizophrenia.
引用
收藏
页码:43 / 53
页数:11
相关论文
共 61 条
  • [31] Improving Current Treatments for Schizophrenia
    Maric, Nadja P.
    Jovicic, Milica J.
    Mihaljevic, Marina
    Miljevic, Cedo
    [J]. DRUG DEVELOPMENT RESEARCH, 2016, 77 (07) : 357 - 367
  • [32] Role of Melatonin in Schizophrenia
    Morera-Fumero, Armando L.
    Abreu-Gonzalez, Pedro
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (05) : 9037 - 9050
  • [33] Gut microbiome in Schizophrenia: Altered functional pathways related to immune modulation and atherosclerotic risk
    Nguyen, Tanya T.
    Kosciolek, Tomasz
    Daly, Rebecca E.
    Vazquez-Baeza, Yoshiki
    Swafford, Austin
    Knight, Rob
    Jeste, Dilip V.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2021, 91 : 245 - 256
  • [34] Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study
    Ni, Jing-Jing
    Xu, Qian
    Yan, Shan-Shan
    Han, Bai-Xue
    Zhang, Hong
    Wei, Xin-Tong
    Feng, Gui-Juan
    Zhao, Min
    Pei, Yu-Fang
    Zhang, Lei
    [J]. FRONTIERS IN MICROBIOLOGY, 2022, 12
  • [35] Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals
    Ormerod, Kate L.
    Wood, David L. A.
    Lachner, Nancy
    Gellatly, Shaan L.
    Daly, Joshua N.
    Parsons, Jeremy D.
    Dal'Molin, Cristiana G. O.
    Palfreyman, Robin W.
    Nielsen, Lars K.
    Cooper, Matthew A.
    Morrison, Mark
    Hansbro, Philip M.
    Hugenholtz, Philip
    [J]. MICROBIOME, 2016, 4
  • [36] Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges
    Paternoster, Lavinia
    Tilling, Kate
    Smith, George Davey
    [J]. PLOS GENETICS, 2017, 13 (10):
  • [37] The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study
    Perry, Benjamin I.
    Burgess, Stephen
    Jones, Hannah J.
    Zammit, Stan
    Upthegrove, Rachel
    Mason, Amy M.
    Day, Felix R.
    Langenberg, Claudia
    Wareham, Nicholas J.
    Jones, Peter B.
    Khandaker, Golam M.
    [J]. PLOS MEDICINE, 2021, 18 (03)
  • [38] Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort
    Qin, Youwen
    Havulinna, Aki S.
    Liu, Yang
    Jousilahti, Pekka
    Ritchie, Scott C.
    Tokolyi, Alex
    Sanders, Jon G.
    Valsta, Liisa
    Brozynska, Marta
    Zhu, Qiyun
    Tripathi, Anupriya
    Vazquez-Baeza, Yoshiki
    Loomba, Rohit
    Cheng, Susan
    Jain, Mohit
    Niiranen, Teemu
    Lahti, Leo
    Knight, Rob
    Salomaa, Veikko
    Inouye, Michael
    Meric, Guillaume
    [J]. NATURE GENETICS, 2022, 54 (02) : 134 - +
  • [39] Rizvi Saliha, 2014, Curr Aging Sci, V7, P161
  • [40] Applications of Mendelian randomization in psychiatry: a comprehensive systematic review
    Saccaro, Luigi F.
    Gasparini, Simone
    Rutigliano, Grazia
    [J]. PSYCHIATRIC GENETICS, 2022, 32 (06) : 199 - 213